Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $32.1600 (0.63%) ($30.4300 - $33.9900) on Fri. Mar. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.2% (three month average) | RSI | 52 | Latest Price | $32.1600(0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 6.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(47%) ARKG(46%) IWO(42%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -4.1% in a week (0% probabilities). VIXM(-25%) UUP(-15%) VXX(-13%) TBT(-2%) UNG(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.1% (StdDev 8.2%) | Hourly BBV | 0 () | Intraday Trend | 4.4% | | | |
|
5 Day Moving Average | $30.09(6.88%) | 10 Day Moving Average | $26.27(22.42%) | 20 Day Moving Average | $29.13(10.4%) | To recent high | -17.2% | To recent low | 64.6% | Market Cap | $4.709b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |